Molecular Signatures and Therapeutic Strategies in Urological Cancers
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 34
Special Issue Editor
Interests: urologic cancers; environmental health; neonatology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue titled “Molecular Signatures and Therapeutic Strategies in Urological Cancers”. Urological malignancies—such as prostate, bladder, kidney, and testicular cancers—remain major clinical challenges due to their heterogeneity and resistance to therapy. Recent advances in molecular profiling have uncovered key genetic, epigenetic, and transcriptomic alterations that deepen our understanding of tumor biology and offer new opportunities for precision medicine.
This Special Issue aims to present cutting-edge research and reviews that explore molecular features and therapeutic innovations in urological cancers. Topics of interest include genomic alterations, non-coding RNAs, epigenetic regulation, and tumor microenvironment dynamics. The scope aligns with the journal’s focus on molecular oncology and personalized medicine, bridging basic research with clinical applications. We aim to gather at least 10 high-quality contributions to form a focused, multidisciplinary collection that may be published in book form.
I look forward to receiving your contributions.
Dr. Haoyue Sheng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urological cancers
- molecular signatures
- precision medicine
- non-coding RNAs
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
